Compare ARK Genomic Revolution ETF (ARKG) vs Open Text Corporation (OTEX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Open Text Corporation — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Open Text Corporation trades at $23.01 (market cap $5.56B). The key difference: Open Text Corporation pays a 4.78% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Open Text Corporation nearer its low. Which is the better fit depends on your goals.
| ARKG | OTEX | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $39.69 |
52-Week Low | $23.09 | $20.01 |
Market Cap | — | $5.56B |
Enterprise Value | — | $10.72B |
Dividend Yield | — | 4.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
OTEX trades at $23.01, up 0.17% today, with a bullish technical signal from moving averages and a consensus analyst price target of $29.75 implying 29% upside. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.994 exceeding expectations, and maintains robust profitability with a 73.06% gross margin. Recent developments include a $105 million investment in European AI and cloud expansion and the divestiture of non-core assets.
The outlook is positive given undervalued metrics like a P/E of 11.17 and EV/EBITDA of 6.7, alongside strategic focus on AI and cloud growth. Risks include execution challenges in integrating new investments and competitive pressures in the tech sector. Investor sentiment is cautiously optimistic, supported by analyst upgrades and institutional interest.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →
